AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 120 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.28 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $521,000 | -64.4% | 11,300 | -57.5% | 0.00% | -60.0% |
| Q2 2021 | $1,465,000 | +100.1% | 26,600 | +27.1% | 0.01% | +66.7% |
| Q3 2020 | $732,000 | +308.9% | 20,931 | +883.1% | 0.00% | +200.0% |
| Q2 2018 | $179,000 | -81.4% | 2,129 | -79.1% | 0.00% | -75.0% |
| Q1 2015 | $961,000 | -18.3% | 10,200 | -2.9% | 0.00% | -20.0% |
| Q4 2014 | $1,176,000 | -29.5% | 10,500 | -61.4% | 0.01% | +25.0% |
| Q3 2014 | $1,668,000 | – | 27,200 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2013 | $67,000 | -23.0% | 2,800 | -9.7% | 0.00% | – |
| Q3 2013 | $87,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |